معرفی
Daphne Haas-Kogan is Chief of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital, and serves as Professor of Radiation Oncology at Harvard Medical School. She specializes in treating pediatric and adult patients with bone tumors, brain tumors, Hodgkin lymphoma, and neuroblastoma through the Dana-Farber/Boston Children's Cancer and Blood Disorders Center in Boston, Massachusetts.
- Medical Degree: University of California, San Francisco (1991)
- Residency: Radiation Oncology, University of California, San Francisco (1997)
- Fellowship: Research, University of California, San Francisco, Diller Family Comprehensive Cancer Center (1994)
Dr. Haas-Kogan's research focuses on optimizing radiation therapy for pediatric CNS malignancies, with particular expertise in brain tumors, neuroblastoma, and ependymoma. Her work spans from basic science investigations of DNA damage response mechanisms to clinical trials evaluating novel radiation approaches and combinations with targeted therapies and immunotherapies. She has pioneered research in hypofractionated radiotherapy, re-irradiation strategies, and the integration of advanced technologies like audiovisual immersion to improve pediatric radiation therapy experiences. Her recent publications demonstrate a strong emphasis on precision medicine approaches, incorporating biomarkers like BRAF status and tumor mutational burden to personalize treatment.
Analysis of her recent publications reveals a consistent focus on improving outcomes for pediatric CNS tumors through innovative radiation approaches. She has led multi-institutional studies examining optimal radiation dosing, developed novel techniques to avoid anesthesia in pediatric patients, and investigated the integration of immunotherapy with radiation. Her work spans the full spectrum from basic molecular mechanisms to health services research examining healthcare disparities and economic considerations in cancer care.
Dr. Haas-Kogan is certified by the American Board of Radiology in Radiation Oncology and has served as Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital since 2015. While specific awards aren't detailed in the provided text, her leadership roles and extensive publication record in high-impact journals reflect significant professional recognition.
As an academic leader, Dr. Haas-Kogan has contributed to numerous Children's Oncology Group studies and has mentored researchers in the field of pediatric radiation oncology. Her work has influenced treatment standards for pediatric CNS tumors and she continues to lead clinical trials investigating novel therapeutic combinations. Her research program encompasses both laboratory investigations of radiation biology and large-scale clinical studies evaluating treatment outcomes across multiple institutions.
Dr. Haas-Kogan leads research initiatives through the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, with particular focus on the Brain Tumor Center, Cancer and Blood Disorders Center, and Radiation Oncology Program. Her team collaborates across multiple institutions to conduct prospective clinical trials and retrospective analyses aimed at improving radiation therapy for pediatric cancer patients while minimizing long-term side effects.
